Skip to main content

Table 2 HRs for risk of outcomes according to quartiles of baseline TyG index

From: Relationship between early-onset stroke and triglyceride-glucose index among young Chinese adults

 

Quartile 1

Quartile 2

Quartile 3

Quartile 4

P for trend

Stroke, N (%)

28(0.31)

58(0.64)

67(0.75)

128(1.42)

 

 Incidence, per1000 person-y

0.27

0.57

0.64

1.22

 

  Model 1

Reference

1.70(1.08–2.68)

1.62(1.04–2.53)

2.50(1.64–3.81)

 < 0.01

  Model 2

Reference

1.65(1.05–2.60)

1.49(0.95–2.34)

2.11(1.38–3.24)

0.01

  Model 3

Reference

1.57(1.00–2.47)

1.35(0.86–2.12)

1.78(1.15–2.74)

0.02

Ischemic stroke, N (%)

19(0.21)

46(0.51)

49(0.55)

107(1.19)

 

 Incidence, per1000 person-y

0.19

0.45

0.47

1.02

 

  Model 1

Reference

1.96(1.14–3.37)

1.70(0.98–2.93)

2.96(1.76–4.96)

 < 0.01

  Model 2

Reference

1.89(1.10–3.25)

1.54(0.89–2.64)

2.40(1.43–4.03)

0.01

  Model 3

Reference

1.78(1.03–3.07)

1.36(0.79–2.36)

1.98(1.17–3.35)

0.02

Hemorrhage stroke, N (%)

10(0.11)

15(0.17)

18(0.20)

23(0.26)

 

 Incidence, per1000 person-y

0.10

0.15

0.17

0.22

 

  Model 1

Reference

1.26(0.57–2.83)

1.28(0.59–2.81)

1.37(0.63–2.95)

0.46

  Model 2

Reference

1.24(0.56–2.78)

1.24(0.56–2.73)

1.31(0.60–2.88)

0.54

  Model 3

Reference

1.23(0.55–2.76)

1.16(0.52–2.58)

1.14(0.51–2.54)

0.86

  1. Model 1: adjusted for age and sex; Model 2: adjusted for age, sex, smoking, drinking, education level, salt status, physical activity, and BMI; Model 3: adjusted for all the variables in model 2 and LDL-C, HDL-C, hs-CRP, hypertension, antidiabetic drugs, antihypertensive drugs and lipid-lowering drugs. TyG indicates triglyceride-glucose